Advertisement
Screener

Q32 Bio Inc. (QTTB) APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

2.0 / 5 stars · 20/50 Roast Me

Q32 Bio Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

Q32 Bio Inc. (QTTB) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-05

  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $1.69M, a 32.89% increase year-over-year.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $1.55M, a 15.35% increase year-over-year.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $1.18M, a 14.91% decline year-over-year.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $1.27M, a 5.09% decline year-over-year.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $5.25M, a 19.81% increase from fiscal 2024.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $4.39M, a 207.14% increase from fiscal 2023.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $1.43M, a 89.06% decline from fiscal 2022.
  • Q32 Bio Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $13.05M, a 24.30% decline from fiscal 2021.
Period endAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filedAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed
2026-06-30$1.69M
10-Q · filed 2026-08-05
$3.23M
derived: sum of 2 quarters · filed 2026-08-05
2026-03-31$1.55M
10-Q · filed 2026-08-05
2025-12-31$5.25M
10-K · filed 2026-03-10
2025-09-30$1.18M
10-Q · filed 2025-11-13
$2.44M
derived: sum of 2 quarters · filed 2026-08-05
$3.79M
derived: sum of 3 quarters · filed 2026-08-05
2025-06-30$1.27M
10-Q · filed 2026-08-05
$2.61M
derived: sum of 2 quarters · filed 2026-08-05
2025-03-31$1.34M
10-Q · filed 2026-08-05
2024-12-31$4.39M
10-K · filed 2026-03-10
2024-09-30$1.38M
10-Q · filed 2025-11-13
$2.72M
derived: sum of 2 quarters · filed 2025-11-13
$3.13M
derived: sum of 3 quarters · filed 2025-11-13
2024-06-30$1.34M
10-Q · filed 2025-11-13
$1.75M
derived: sum of 2 quarters · filed 2025-11-13
2024-03-31$417.00K
10-Q · filed 2025-11-13
2023-12-31$1.43M
10-K · filed 2025-03-11
$7.32M
10-K · filed 2024-03-13
2023-09-30$301.00K
10-Q · filed 2024-11-07
$1.71M
10-Q · filed 2023-11-14
$611.00K
derived: sum of 2 quarters · filed 2024-11-07
$907.00K
derived: sum of 3 quarters · filed 2024-11-07
2023-06-30$310.00K
10-Q · filed 2024-11-07
$2.40M
10-Q · filed 2023-08-14
$606.00K
derived: sum of 2 quarters · filed 2024-11-07
2023-03-31$296.00K
10-Q · filed 2024-11-07
$2.37M
10-Q · filed 2023-05-11
2022-12-31$13.05M
10-K · filed 2024-03-13
2022-09-30$2.77M
10-Q · filed 2023-11-14
$5.91M
derived: sum of 2 quarters · filed 2023-11-14
$9.96M
derived: sum of 3 quarters · filed 2023-11-14
2022-06-30$3.14M
10-Q · filed 2023-11-14
$7.19M
derived: sum of 2 quarters · filed 2023-11-14
2022-03-31$4.05M
10-Q · filed 2023-11-14
2021-12-31$17.25M
10-K · filed 2023-03-09
2021-09-30$4.23M
10-Q · filed 2022-11-10
$8.70M
derived: sum of 2 quarters · filed 2022-11-10
$12.58M
derived: sum of 3 quarters · filed 2022-11-10
2021-06-30$4.47M
10-Q · filed 2022-11-10
$8.36M
derived: sum of 2 quarters · filed 2022-11-10
2021-03-31$3.88M
10-Q · filed 2022-11-10
2020-12-31$13.25M
10-K · filed 2022-03-23
2020-09-30$3.35M
10-Q · filed 2021-11-15
$6.80M
derived: sum of 2 quarters · filed 2021-11-15
$9.68M
derived: sum of 3 quarters · filed 2021-11-15
2020-06-30$3.45M
10-Q · filed 2021-11-15
$6.34M
derived: sum of 2 quarters · filed 2021-11-15
2020-03-31$2.88M
10-Q · filed 2021-11-15
2019-12-31$7.63M
10-K · filed 2021-03-11
2019-09-30$1.99M
10-Q · filed 2020-11-09
$3.96M
derived: sum of 2 quarters · filed 2020-11-09
$5.20M
derived: sum of 3 quarters · filed 2020-11-09
2019-06-30$1.97M
10-Q · filed 2020-11-09
$3.21M
derived: sum of 2 quarters · filed 2020-11-09
2019-03-31$1.24M
10-Q · filed 2020-11-09
2018-12-31$2.62M
10-K · filed 2020-03-12
2018-09-30$719.00K
10-Q · filed 2019-11-12
$1.29M
derived: sum of 2 quarters · filed 2019-11-12
$1.67M
derived: sum of 3 quarters · filed 2019-11-12
2018-06-30$569.00K
10-Q · filed 2019-11-12
$949.00K
derived: sum of 2 quarters · filed 2019-11-12
2018-03-31$380.00K
10-Q · filed 2019-11-12
2017-12-31$256.00K
10-K · filed 2019-03-12